Displaying 10 of 24 results
Fundraising rounds risk to R&D tax credits for life sciences businesses
James Tetley

16 August 2021

Life sciences businesses risk losing access to R&D tax credits during fundraising rounds.

RDEC Scheme | R&D tax relief explained
James Tetley

22 July 2021

We explain how the RDEC scheme works, what rate of relief is available, what expenditure qualifies for the relief and the evidence required for your claim. We also cover how large corporations and SMEs can make best use of the scheme and how we can help.

Businesses should review the cash-flow impact of the reintroduced cap on payable SME tax credits
James Tetley

25 March 2021

From 1 April 2021, small and medium-sized enterprises (SMEs) considering making a research and development (R&D) tax relief claim will need to carefully consider the impact of a new cap on payable tax credits.

R&D tax incentives key to UK at forefront of innovation
James Tetley

03 March 2021

The Chancellors plan to launch a review of the current Research and Development (R&D) tax incentives builds on previous consultation, revealing the Government’s focus towards keeping the UK at the forefront of innovation.

R&D claimable areas by sector
James Tetley

07 December 2020

Despite relief being available for both small and large companies, eligible R&D is often overlooked outside of certain activities.

UK businesses receive £33.3bn in R&D tax relief since inception in 2000, with biggest rise in claims for last year from SMEs
James Tetley

02 October 2020

The latest HMRC statistics on Research & Development tax relief reveal that in 20 years, over 300,000 claims have been made, delivering £33.3bn of tax relief to UK businesses since its introduction in 2000.

Promising signs of R&D reform for a digital age
James Tetley

18 September 2020

Following the Governments third consultation on research and development (R&D) tax reliefs of 2020 in early July, we explore the promising signs to bring the regime into the current digital age.

By relaxing R&D tax relief criteria, Government could help boost capital expenditure
James Tetley

23 June 2020

The extent of planned capital expenditure (capex) cuts by large listed companies in the UK was last week predicted to reach somewhere in the region of £23bn. CFOs seem to favour cash preservation over investment. What can Government do to lure business leaders away from their spending funk? Boosting the level of R&D tax relief available and relaxing the qualifying criteria would be a good starting point.

Coronavirus tax deferrals will not be offset against R&D credits
Philip Munn

21 April 2020

Following enquiries by RSM, HMRC has confirmed that R&D repayment claims will not be offset against tax liabilities under COVID-19 deferral schemes. However, payments of tax that are delayed under time-to-pay agreements with HMRC remain subject to offset.

HMRC confirms R&D repayment claims will not be offset against tax liabilities under deferral agreements
James Tetley

20 April 2020

RSM has contacted HMRC’s policy team to ask how R&D repayment claims will be treated in light of the government’s support schemes to help businesses cope with the coronavirus outbreak. Find out the answer here.